Jeff Aronin

1 POSTS 0 COMMENTS
Jeff Aronin is chairman and CEO of Paragon Biosciences, which, along with partners, has invested approximately $1 billion in portfolio companies since 2017 and expects ongoing investments of up to $500 million annually.

How One CEO Is Changing Life Sciences Innovation

Using a unique company incubator approach, Paragon Biosciences boasts an 80%–90% approval rate on new drug applications, far exceeding that of the traditional pharma industry.
- Advertisement -
- Advertisement -

SUBSCRIBE TO CHIEF EXECUTIVE

Sign Up to Receive Chief Executive Magazine

Chief Executive’s publications are designed to help CEOs do their jobs better and run their businesses more effectively. Subscribe here.

CEO CONFIDENCE INDEX

July Poll Finds CEO Confidence Rebounding To Multi-Year High 

Chief Executive’s latest poll of U.S. CEOs finds surging optimism, as buoyant consumer demand and return-to-office policies swamp inflation worries.